Literature DB >> 20186813

Novel ANKH mutation in a patient with sporadic craniometaphyseal dysplasia.

Allison Zajac1, Seung-Hak Baek, Imad Salhab, Melissa A Radecki, Sukwha Kim, Hakon Hakonarson, Hyun-Duck Nah.   

Abstract

Craniometaphyseal dysplasia is caused by mutations in ANKH (ankylosis, progressive homolog [mouse]) in the majority of cases, and all of the reported mutations are single amino acid changes. Genomic DNA from an affected patient, his biological parents, and a sibling was amplified and ANKH was sequenced. The affected patient had a complex heterozygous mutation in exon 7 (c.936T > C, c.938C > G, c.942_953delTGGTTGACGGAA), predicting p.Try290Gln and p.Trp292_Glu295del. We studied the effect of the predicted mutation on the subcellular distribution of ANKH protein. Immunofluorescent labeling of COS-7 cells transduced with normal or mutant Ank (murine progressive ankylosis), showed that normal Ank localized to both the plasma membrane and cytoplasm, whereas mutant Ank was detected only in the cytoplasmic compartment. We propose that this craniometaphyseal dysplasia mutation causes a loss of ANKH protein expression and activity in the plasma membrane as a result of aberrant intracellular protein trafficking. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186813      PMCID: PMC2944898          DOI: 10.1002/ajmg.a.33317

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  20 in total

1.  Craniometaphyseal dysplasia: a case report and review of medical and surgical management.

Authors:  William M Sheppard; Robert J Shprintzen; Sherard A Tatum; Charles I Woods
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-06       Impact factor: 1.675

Review 2.  Craniometaphyseal dysplasia: a case report and review of medical and surgical management.

Authors:  William M Sheppard; Robert J Shprintzen; Sherard A Tatum; Charles I Woods
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-01       Impact factor: 1.675

3.  Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK.

Authors:  E Reichenberger; V Tiziani; S Watanabe; L Park; Y Ueki; C Santanna; S T Baur; R Shiang; D K Grange; P Beighton; J Gardner; H Hamersma; S Sellars; R Ramesar; A C Lidral; A Sommer; C M Raposo do Amaral; R J Gorlin; J B Mulliken; B R Olsen
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

4.  Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia.

Authors:  P Nürnberg; H Thiele; D Chandler; W Höhne; M L Cunningham; H Ritter; G Leschik; K Uhlmann; C Mischung; K Harrop; J Goldblatt; Z U Borochowitz; D Kotzot; F Westermann; S Mundlos; H S Braun; N Laing; S Tinschert
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

5.  Dominant craniometaphyseal dysplasia--a family study over five generations.

Authors:  D B Taylor; P Sprague
Journal:  Australas Radiol       Date:  1989-02

6.  Craniometaphyseal dysplasia (CMD), autosomal dominant form.

Authors:  P Beighton
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

7.  Mutations in ANKH cause chondrocalcinosis.

Authors:  Adrian Pendleton; Michelle D Johnson; Anne Hughes; Kyle A Gurley; Andrew M Ho; Michael Doherty; Josh Dixey; Pierre Gillet; Damien Loeuille; Rodney McGrath; Antonio Reginato; Rita Shiang; Gary Wright; Patrick Netter; Charlene Williams; David M Kingsley
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

8.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

9.  Autosomal dominant craniometaphyseal dysplasia. Clinical variability.

Authors:  A Carnevale; P Grether; V del Castillo; R Takenaga; A Orzechowski
Journal:  Clin Genet       Date:  1983-01       Impact factor: 4.438

10.  Bone marrow-derived osteoclast-like cells from a patient with craniometaphyseal dysplasia lack expression of osteoclast-reactive vacuolar proton pump.

Authors:  T Yamamoto; N Kurihara; K Yamaoka; K Ozono; M Okada; K Yamamoto; S Matsumoto; T Michigami; J Ono; S Okada
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more
  6 in total

1.  Craniometaphyseal Dysplasia: A review and novel oral manifestation.

Authors:  K Martin; S Nathwani; R Bunyan
Journal:  J Oral Biol Craniofac Res       Date:  2017-05-06

2.  Dental abnormalities in a mouse model for craniometaphyseal dysplasia.

Authors:  E H Dutra; I-P Chen; E J Reichenberger
Journal:  J Dent Res       Date:  2012-11-15       Impact factor: 6.116

3.  Two novel large ANKH deletion mutations in sporadic cases with craniometaphyseal dysplasia.

Authors:  E H Dutra; I-P Chen; T L McGregor; J D Ranells; E J Reichenberger
Journal:  Clin Genet       Date:  2012-01       Impact factor: 4.438

4.  A novel autosomal recessive GJA1 missense mutation linked to Craniometaphyseal dysplasia.

Authors:  Ying Hu; I-Ping Chen; Salome de Almeida; Valdenize Tiziani; Cassio M Raposo Do Amaral; Kalpana Gowrishankar; Maria Rita Passos-Bueno; Ernst J Reichenberger
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 5.  Extracellular pyrophosphate in the kidney: how does it get there and what does it do?.

Authors:  Shabbir H Moochhala
Journal:  Nephron Physiol       Date:  2012-10-12

6.  Rapid degradation of progressive ankylosis protein (ANKH) in craniometaphyseal dysplasia.

Authors:  Jitendra Kanaujiya; Edward Bastow; Raj Luxmi; Zhifang Hao; Dimitrios Zattas; Mark Hochstrasser; Ernst J Reichenberger; I-Ping Chen
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.